Nanofat Grafting for Treatment of Androgenetic Alopecia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03506503|
Recruitment Status : Not yet recruiting
First Posted : April 24, 2018
Last Update Posted : May 18, 2018
|Condition or disease||Intervention/treatment||Phase|
|Androgenic Alopecia||Procedure: Nanofat grafting||Not Applicable|
The investigators will treat the hair loss area of a patient by processed nanofat grafting. The participants were asked to come back 1、3、6、9、12 months after treatment for further follow-up.
Before and after the treatment, the hair and follicular will be assessed subjectively by satisfaction assessment, dermatoscope.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Nanofat Grafting for Treatment of Androgenetic Alopecia|
|Estimated Study Start Date :||June 1, 2018|
|Estimated Primary Completion Date :||June 1, 2020|
|Estimated Study Completion Date :||June 1, 2020|
Experimental: processed Nanofat grafting
processed autologous Nanofat will be injected into the area of the scalp with androgenic alopecia.
Procedure: Nanofat grafting
hair loss area will be treated by processed autologous Nanofat grafting
- Dermatoscope [ Time Frame: Baseline and at1,3,6,9,12 months after the treatment ]the density of hair follicle and diameter of hair will be analized by dermatoscope before and after the treatment of Nanofat grafting.
- Satisfaction assessments [ Time Frame: 1,3,6,12 months after treatment ]the satisfaction will be assessed after the treatment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03506503
|Contact: hongwei email@example.com|
|the first affiliated hospital of Jinan University|
|Guangzhou, Guangdong, China, 510000|